These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 17888184)

  • 1. Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivo.
    Gorry PR; McPhee DA; Verity E; Dyer WB; Wesselingh SL; Learmont J; Sullivan JS; Roche M; Zaunders JJ; Gabuzda D; Crowe SM; Mills J; Lewin SR; Brew BJ; Cunningham AL; Churchill MJ
    Retrovirology; 2007 Sep; 4():66. PubMed ID: 17888184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphoproliferative immune function in the Sydney Blood Bank Cohort, infected with natural nef/long terminal repeat mutants, and in other long-term survivors of transfusion-acquired HIV-1 infection.
    Dyer WB; Geczy AF; Kent SJ; McIntyre LB; Blasdall SA; Learmont JC; Sullivan JS
    AIDS; 1997 Nov; 11(13):1565-74. PubMed ID: 9365760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistence of attenuated HIV-1 rev alleles in an epidemiologically linked cohort of long-term survivors infected with nef-deleted virus.
    Churchill MJ; Chiavaroli L; Wesselingh SL; Gorry PR
    Retrovirology; 2007 Jul; 4():43. PubMed ID: 17601342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral phenotypes and antibody responses in long-term survivors infected with attenuated human immunodeficiency virus type 1 containing deletions in the nef and long terminal repeat regions.
    Verity EE; Zotos D; Wilson K; Chatfield C; Lawson VA; Dwyer DE; Cunningham A; Learmont J; Dyer W; Sullivan J; Churchill M; Wesselingh SL; Gabuzda D; Gorry PR; McPhee DA
    J Virol; 2007 Sep; 81(17):9268-78. PubMed ID: 17567690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotype and envelope gene diversity of nef-deleted HIV-1 isolated from long-term survivors infected from a single source.
    Gray L; Churchill MJ; Sterjovski J; Witlox K; Learmont JC; Sullivan JS; Wesselingh SL; Gabuzda D; Cunningham AL; McPhee DA; Gorry PR
    Virol J; 2007 Jul; 4():75. PubMed ID: 17634131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An examination of signs of disease progression in survivors of the Sydney Blood Bank Cohort (SBBC).
    Birch MR; Learmont JC; Dyer WB; Deacon NJ; Zaunders JJ; Saksena N; Cunningham AL; Mills J; Sullivan JS
    J Clin Virol; 2001 Oct; 22(3):263-70. PubMed ID: 11564591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Sydney Blood Bank Cohort: implications for viral fitness as a cause of elite control.
    Zaunders J; Dyer WB; Churchill M
    Curr Opin HIV AIDS; 2011 May; 6(3):151-6. PubMed ID: 21378562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of long-term infection with nef-defective attenuated HIV type 1 on CD4+ and CD8+ T lymphocytes: increased CD45RO+CD4+ T lymphocytes and limited activation of CD8+ T lymphocytes.
    Zaunders JJ; Geczy AF; Dyer WB; McIntyre LB; Cooley MA; Ashton LJ; Raynes-Greenow CH; Learmont J; Cooper DA; Sullivan JS
    AIDS Res Hum Retroviruses; 1999 Nov; 15(17):1519-27. PubMed ID: 10580402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal analysis of human immunodeficiency virus type 1 nef/long terminal repeat sequences in a cohort of long-term survivors infected from a single source.
    Churchill MJ; Rhodes DI; Learmont JC; Sullivan JS; Wesselingh SL; Cooke IR; Deacon NJ; Gorry PR
    J Virol; 2006 Jan; 80(2):1047-52. PubMed ID: 16379007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Replication-dependent pathogenicity of attenuated nef-deleted HIV-1 in vivo.
    Gorry PR; Churchill M; Learmont J; Cherry C; Dyer WB; Wesselingh SL; Sullivan JS
    J Acquir Immune Defic Syndr; 2007 Dec; 46(4):390-4. PubMed ID: 17993857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MVA-nef induces HIV-1-specific polyfunctional and proliferative T-cell responses revealed by the combination of short- and long-term immune assays.
    Kutscher S; Allgayer S; Dembek CJ; Bogner JR; Protzer U; Goebel FD; Erfle V; Cosma A
    Gene Ther; 2010 Nov; 17(11):1372-83. PubMed ID: 20535218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1-specific CD8 T cell responses in a pediatric slow progressor infected as a premature neonate.
    Chakraborty R; Gillespie GM; Reinis M; Rostron T; Dong T; Philpott S; Burger H; Weiser B; Peto T; Rowland-Jones SL
    AIDS; 2002 Oct; 16(15):2085-7. PubMed ID: 12370511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic and functional analysis of HIV type 1 nef gene derived from long-term nonprogressor children: association of attenuated variants with slow progression to pediatric AIDS.
    Corró G; Rocco CA; De Candia C; Catano G; Turk G; Mangano A; Aulicino PC; Bologna R; Sen L
    AIDS Res Hum Retroviruses; 2012 Dec; 28(12):1617-26. PubMed ID: 22583022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serological detection of attenuated HIV-1 variants with nef gene deletions.
    Greenway AL; Mills J; Rhodes D; Deacon NJ; McPhee DA
    AIDS; 1998 Apr; 12(6):555-61. PubMed ID: 9583594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A nonprogressive clinical course in HIV-infected individuals expressing human leukocyte antigen B57/5801 is associated with preserved CD8+ T lymphocyte responsiveness to the HW9 epitope in Nef.
    Navis M; Schellens IM; van Swieten P; Borghans JA; Miedema F; Kootstra NA; van Baarle D; Schuitemaker H
    J Infect Dis; 2008 Mar; 197(6):871-9. PubMed ID: 18279072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a new recipient in the Sydney Blood Bank Cohort: a long-term HIV type 1-infected seroindeterminate individual.
    Rhodes D; Solomon A; Bolton W; Wood J; Sullivan J; Learmont J; Deacon N
    AIDS Res Hum Retroviruses; 1999 Nov; 15(16):1433-9. PubMed ID: 10555106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nef Proteins from HIV-1 Elite Controllers Are Inefficient at Preventing Antibody-Dependent Cellular Cytotoxicity.
    Alsahafi N; Ding S; Richard J; Markle T; Brassard N; Walker B; Lewis GK; Kaufmann DE; Brockman MA; Finzi A
    J Virol; 2015 Dec; 90(6):2993-3002. PubMed ID: 26719277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of a new HIV-1 DNA construct in a BALB/c mouse model.
    Mahdavi M; Ebtekar M; Mahboudi F; Khorram Khorshid H; Rahbarizadeh F; Azadmanesh K; Darabi H; Pourasgari F; Hassan ZM
    Iran J Immunol; 2009 Dec; 6(4):163-73. PubMed ID: 20054104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of CD8+ T-cell-mediated selective pressure on human immunodeficiency virus type 1 nef in HLA-B*57+ elite suppressors.
    Bailey JR; Brennan TP; O'Connell KA; Siliciano RF; Blankson JN
    J Virol; 2009 Jan; 83(1):88-97. PubMed ID: 18945771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of human immunodeficiency virus (HIV)-specific T-cell immunity in control of dual HIV-1 and HIV-2 infection.
    Zheng NN; McElrath MJ; Sow PS; Hawes SE; Diallo-Agne H; Stern JE; Li F; Mesher AL; Robinson AD; Gottlieb GS; Huang Y; Kiviat NB
    J Virol; 2007 Sep; 81(17):9061-71. PubMed ID: 17582003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.